Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Oct 16, 2025

Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells
06:32

Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells

Published on: September 1, 2010

16.5K

SEQing to find hidden medulloblastoma cells.

John R Prensner1, Scott L Pomeroy2

  • 1Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Harvard Medical School, Boston, MA 02115, USA.

Cancer Cell
|October 22, 2021
PubMed
Summary

Measuring minimal residual disease (MRD) in pediatric brain tumors is now possible using cell-free DNA in cerebrospinal fluid. This breakthrough offers crucial prognostic insights for medulloblastoma patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Author Correction: Community benchmarking and evaluation of human unannotated microprotein detection by mass spectrometry based proteomics.

Nature communications·2026
Same author

Expanding the human proteome with microproteins and peptideins.

Nature·2026
Same author

Pediatric Spinal Atypical Teratoid Rhabdoid Tumor: Recent Advances in Biology and Management Options.

Cancers·2026
Same author

Microproteins in Human Physiology and Pathology.

Biochemistry·2026
Same author

An expanded reference catalog of translated open reading frames for biomedical research.

Nucleic acids research·2026
Same author

FGFR1:TACC1-Fused Pilocytic Astrocytoma in a Child With Muenke Syndrome: A Case Report.

Pediatric blood & cancer·2026

Area of Science:

  • Neuro-oncology
  • Molecular diagnostics
  • Pediatric oncology

Background:

  • Minimal residual disease (MRD) assessment significantly impacts pediatric leukemia management.
  • Implementing MRD assessment in pediatric brain tumors presents considerable challenges.

Purpose of the Study:

  • To describe a novel method for MRD assessment in pediatric medulloblastoma.
  • To evaluate the prognostic value of this MRD assessment technique.

Main Methods:

  • Utilized cell-free DNA (cfDNA) analysis in cerebrospinal fluid (CSF).
  • Developed a method for detecting cfDNA specific to pediatric medulloblastoma.

Main Results:

  • Successfully established a method to measure MRD in pediatric medulloblastoma.

More Related Videos

Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice
05:10

Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice

Published on: October 3, 2010

12.3K
Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
04:01

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics

Published on: March 15, 2024

1.3K

Related Experiment Videos

Last Updated: Oct 16, 2025

Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells
06:32

Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells

Published on: September 1, 2010

16.5K
Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice
05:10

Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice

Published on: October 3, 2010

12.3K
Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
04:01

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics

Published on: March 15, 2024

1.3K
  • Demonstrated significant prognostic implications of MRD levels detected via cfDNA in CSF.

    • Conclusions:

    • Cell-free DNA in CSF provides a viable approach for MRD assessment in pediatric medulloblastoma.
    • This method holds promise for improving risk stratification and clinical management of these young patients.